Home  /  Resource Library  /  Analysis of Immune-Related Adverse Reactions in Patients with Classical Hodgkin Lymphoma (cHL) on Programmed Death-1 (PD-1) Inhibitor Therapy

Analysis of Immune-Related Adverse Reactions in Patients with Classical Hodgkin Lymphoma (cHL) on Programmed Death-1 (PD-1) Inhibitor Therapy

Results of a study examining the rate of side effects following treatment for Hodgkin lymphoma with immune checkpoint inhibitors.